Sesen Bio's Series A Round

Sesen Bio raised a round of funding on February 05, 2010.

Sesen Bio, formerly Eleven Biotherapeutics, is a late-stage company developing next-generation antibody-drug conjugate (ADC) therapies for patients with cancer.…

Articles about Sesen Bio's Series A Round: